Search results
How Jennifer Doudna's Life Has Changed Since Discovering CRISPR 10 Years Ago
Time via Yahoo News· 2 years agoDr. Jennifer Doudna in Berkeley, Calif., on Jan. 18, 2019. Credit - Anastasiia Sapon—The New York...
Bull of the Day: CRISPR Therapeutics (CRSP)
Zacks via Yahoo Finance· 5 months agoCRISPR Therapeutics (CRSP) just made history on Friday with the first FDA-approved gene-editing medicine based on the Nobel Prize-winning discovery that...
Guest column: Why new DNA research changes how scientists study disease
The Oklahoman via Yahoo News· 1 year agoThe year is at a stage where it’s pretty much all possibility. Sure, a resolution or two may have...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via Yahoo News· 4 days agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
InvestorPlace via Yahoo Finance· 1 year agoThe 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work...
FDA Approves First CRISPR Treatment in U.S.
Time via Yahoo News· 5 months agoSickled blood cells forming clumps in a vessel Credit - Getty Images It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier...
Editas cashes in on CRISPR patent with Vertex deal
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: Days after winning U.S. approval of the first CRISPR gene-editing medicine, Vertex Pharmaceuticals is clearing up potential intellectual...
The 7 Best Biotech Stocks to Buy
InvestorPlace via Yahoo Finance· 2 years agoI’ve written before about how biotech is the biggest technology trend of our kids’ generation. Naturally, that means many people are looking for the best...
After a decade, CRISPR gene editing is a 'revolution in progress.' What does the future hold?
USA TODAY via Yahoo News· 1 year agoMedical innovations typically take 17 years from the time a lightbulb goes off in a scientist's head...
The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2...
Business Insider via Yahoo News· 5 months agoThe FDA approved the first gene therapy for sickle cell anemia.Meletios Verras/ iStock The FDA...
